Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

New Jersey Innovation Institute Introduces Two Groundbreaking Biopharmaceutical Centers

6/23/2017

0 Comments

 
Newark, NJ — Companies in every sector are realizing that manufacturing matters.  For the biopharmaceutical industry, innovation is not about reducing unit part costs; instead, process technology is a strategic tool to reduce time to market, ensure consistent product quality and streamline regulatory approval.
 
As rapidly as science is advancing drug discovery, so too, must production technology keep pace.  But where will such innovation happen? 
 
The New Jersey Innovation Institute (NJII) is answering this question.
 
The Biotechnology and Pharmaceutical Innovation iLab at NJII provides a collaborative platform for industry, technology developers, academia and regulatory agencies to develop, integrate and demonstrate manufacturing solutions. 
​It will also train the workforce to operate next-generation production systems for this industry.
 
Haro Hartounian, Ph.D., NJII’s Executive Director Biotechnology & Pharmaceutical Innovation, is leading the Biotechnology and Pharmaceutical iLab which announces two related centers tackling the priorities of bulk and low volume production for small molecule, biologic and cell-based therapies.
 
The Continuous Pharmaceutical Manufacturing Center of New Jersey (CPMC) is a joint venture between NJII and Rutgers University that builds on a decade of pioneering work by Fernando Muzzio, Ph.D., Distinguished Professor of Chemical and Biochemical Engineering at Rutgers University.
 
Dr. Muzzio’s National Science Foundation Engineering Research Center for Structured Organic Particulate Solids (CSOPS) has led the way in advancing small molecule continuous manufacturing and is extending these methodologies to biologics in this new center.
 
Dr. Muzzio’s multi university team has already assisted in commercializing continuous manufacturing of new solid dose therapies with order of magnitude scale reductions in process footprint and capital expense, while also taking years off the manufacturing development and approval process.
 
NJII’s Cell and Gene Therapy Development Center of New Jersey will offer process development and training and workforce development solutions to the industry for this rapidly developing market.
 
While the CPMC addresses the challenge of mass production through continuous processing, these therapies are more likely to be patient specific and yet still require cost-effective production technology if they are to scale to market need.
 
The Center brings together big pharma, emerging bio-techs, equipment vendors and instrumentation companies together with regulatory agencies to pioneer such development and train those who will take the technology into commercial practice.
 
By combining state-of-the-art technologies, infrastructure, facilities and know-how both centers have the potential to significantly reduce the cost of manufacturing for both existing and new categories of advanced biopharmaceuticals. The facility will have a pilot plant for process development, training labs and rooms
 
Advances in biopharmaceutical products have entered a new era of discovery and treatment. Products only dreamed of a few years ago are now a reality and offer unprecedented promise for the treatment of a wide range of diseases.
 
NJII’s Cell and Gene Therapy Development Center of New Jersey and the Continuous Pharmaceutical Manufacturing Center of New Jersey are dedicated to working with the world’s leading pharmaceutical manufacturers to bring these new medicines to all, faster and at reduced cost to produce.
 
The New Jersey Innovation Institute (NJII) is an NJIT corporation that applies the intellectual and technological resources of the state’s science and technology university to challenges identified by industry partners.
 
Through its Innovation Labs (iLabs), NJII brings NJIT expertise to key economic sectors, including healthcare delivery systems, bio-pharmaceutical production, civil infrastructure, defense and homeland security, and financial services.
 
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
222 West State Street
Suite 302
Trenton, NJ 08608
732-729-9619